AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39908757|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|39908757|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40041255|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40202922|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40435594|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40609057|Female|Anaplastic astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998778|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|39908757|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40041255|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|40202922|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|40435594|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40609057|Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|39998778|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39908757|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39908757|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40041255|Female|Choroid plexus|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40041255|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40202922|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40202922|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40435594|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40435594|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|40609057|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40609057|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|39998778|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998778|Female|Choroid plexus|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|39908757|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39908757|Female|Craniopharyngioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40041255|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40041255|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40202922|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40202922|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40435594|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40435594|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|61|40609057|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40609057|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|39998778|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39998778|Female|Craniopharyngioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39908757|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40041255|Female|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40435594|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40609057|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|39998778|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|39908757|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|183|40041255|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40202922|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|217|40435594|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|230|40609057|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.5|0.5|Malignant|188|39998778|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|39908757|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|40041255|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40202922|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40435594|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|40609057|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|39998778|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39908757|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|46|40041255|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Germ Cell Tumors|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40202922|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|40435594|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Germ Cell Tumors|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40609057|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998778|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|41|39998778|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39908757|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40041255|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40202922|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40435594|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40609057|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998778|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|226|39908757|Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|221|40041255|Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|233|40202922|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|247|40435594|Female|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|251|40609057|Female|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|257|39998778|Female|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40041255|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40041255|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40435594|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40435594|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40041255|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40041255|Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40202922|Female|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40202922|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40435594|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40435594|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40609057|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40609057|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|39998778|Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39998778|Female|Hemangioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39908757|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39908757|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40041255|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40041255|Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|40202922|Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40202922|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40435594|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40435594|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40609057|Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40609057|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|39998778|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39998778|Female|Meningioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|39908757|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40041255|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40435594|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40609057|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|39998778|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|39908757|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|39908757|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|51|40041255|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|40041255|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|46|40202922|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40202922|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|48|40435594|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|40435594|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|63|40609057|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|40609057|Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|39998778|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|39998778|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|100|39908757|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39908757|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|40041255|Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40041255|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40202922|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40202922|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|40435594|Female|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40435594|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|40609057|Female|Nerve sheath, benign and malignant|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40609057|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|39998778|Female|Nerve sheath, benign and malignant|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39998778|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40609057|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Neuroepithelial|2009|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|39908757|Female|Neuronal/glial, neuronal|2004|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|21|39908757|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|132|40041255|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40041255|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|116|40202922|Female|Neuronal/glial, neuronal|2006|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|24|40202922|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|129|40435594|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|30|40435594|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|126|40609057|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40609057|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|123|39998778|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39998778|Female|Neuronal/glial, neuronal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39908757|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40041255|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40202922|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40435594|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40609057|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Other mesenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40202922|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40202922|Female|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40609057|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40609057|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|39998778|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998778|Female|Other mesenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|320|39908757|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|315|40041255|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|306|40202922|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|323|40435594|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|320|40609057|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.9|0.8|Malignant|309|39998778|Female|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39908757|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39908757|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|40041255|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|40041255|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40202922|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40202922|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40435594|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40435594|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40609057|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40609057|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39998778|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|39998778|Female|Pineal parenchymal|2009|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|247|39908757|Female|Pituitary|2004|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|39908757|Female|Pituitary|2004|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|260|40041255|Female|Pituitary|2005|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|40041255|Female|Pituitary|2005|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|284|40202922|Female|Pituitary|2006|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|40202922|Female|Pituitary|2006|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|273|40435594|Female|Pituitary|2007|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|40435594|Female|Pituitary|2007|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|290|40609057|Female|Pituitary|2008|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|40609057|Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|259|39998778|Female|Pituitary|2009|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|39998778|Female|Pituitary|2009|~|~|~
0-19|1.8|2.0|1.9|Benign/Borderline|758|39908757|Female|Total|2004|1.8|2.0|1.9
0-19|3.0|3.4|3.2|Malignant|1271|39908757|Female|Total|2004|3.0|3.4|3.2
0-19|1.9|2.2|2.1|Benign/Borderline|839|40041255|Female|Total|2005|2.0|2.2|2.1
0-19|2.8|3.2|3.0|Malignant|1197|40041255|Female|Total|2005|2.8|3.2|3.0
0-19|1.9|2.2|2.1|Benign/Borderline|831|40202922|Female|Total|2006|1.9|2.2|2.1
0-19|2.8|3.1|3.0|Malignant|1191|40202922|Female|Total|2006|2.8|3.1|3.0
0-19|2.0|2.2|2.1|Benign/Borderline|852|40435594|Female|Total|2007|2.0|2.3|2.1
0-19|2.9|3.3|3.1|Malignant|1263|40435594|Female|Total|2007|3.0|3.3|3.1
0-19|2.0|2.3|2.1|Benign/Borderline|866|40609057|Female|Total|2008|2.0|2.3|2.1
0-19|2.8|3.2|3.0|Malignant|1228|40609057|Female|Total|2008|2.9|3.2|3.0
0-19|1.9|2.2|2.0|Benign/Borderline|817|39998778|Female|Total|2009|1.9|2.2|2.0
0-19|2.7|3.1|2.9|Malignant|1158|39998778|Female|Total|2009|2.7|3.1|2.9
0-19|0.2|0.3|0.3|Benign/Borderline|100|39908757|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39908757|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|40041255|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40041255|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40202922|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40202922|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|40435594|Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40435594|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|40609057|Female|Tumors of Cranial and Spinal Nerves|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40609057|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|39998778|Female|Tumors of Cranial and Spinal Nerves|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39998778|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|191|39908757|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|1178|39908757|Female|Tumors of Neuroepthelial Tissue|2004|2.8|3.1|3.0
0-19|0.4|0.5|0.5|Benign/Borderline|186|40041255|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
0-19|2.6|2.9|2.8|Malignant|1108|40041255|Female|Tumors of Neuroepthelial Tissue|2005|2.6|2.9|2.8
0-19|0.4|0.5|0.5|Benign/Borderline|191|40202922|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
0-19|2.6|3.0|2.8|Malignant|1123|40202922|Female|Tumors of Neuroepthelial Tissue|2006|2.6|3.0|2.8
0-19|0.5|0.6|0.5|Benign/Borderline|214|40435594|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.5
0-19|2.8|3.1|2.9|Malignant|1193|40435594|Female|Tumors of Neuroepthelial Tissue|2007|2.8|3.1|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|204|40609057|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1172|40609057|Female|Tumors of Neuroepthelial Tissue|2008|2.7|3.1|2.9
0-19|0.4|0.5|0.5|Benign/Borderline|183|39998778|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
0-19|2.5|2.9|2.7|Malignant|1080|39998778|Female|Tumors of Neuroepthelial Tissue|2009|2.5|2.9|2.7
0-19|0.7|0.9|0.8|Benign/Borderline|332|39908757|Female|Tumors of Sellar Region|2004|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39908757|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|335|40041255|Female|Tumors of Sellar Region|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40041255|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|359|40202922|Female|Tumors of Sellar Region|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40202922|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|364|40435594|Female|Tumors of Sellar Region|2007|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40435594|Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|351|40609057|Female|Tumors of Sellar Region|2008|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40609057|Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|342|39998778|Female|Tumors of Sellar Region|2009|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998778|Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39908757|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39908757|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|40041255|Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40041255|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40202922|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40202922|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|40435594|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40435594|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|40609057|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40609057|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|39998778|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39998778|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|39908757|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|39908757|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|74|40041255|Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|40041255|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|40202922|Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|40202922|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|70|40435594|Female|Unclassified Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|20|40435594|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|98|40609057|Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|19|40609057|Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|93|39998778|Female|Unclassified Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|18|39998778|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|18|39908757|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|39908757|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|20|40041255|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|40041255|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|23|40202922|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40202922|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|40435594|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|33|40435594|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40609057|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40609057|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998778|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|39998778|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41911213|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41911213|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|42031490|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|42186878|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|42421376|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42588547|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|41939120|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|104|41911213|Male|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|42031490|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42186878|Male|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|42421376|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|42588547|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|41939120|Male|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|28|41911213|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41911213|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42031490|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42031490|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42186878|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42186878|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42421376|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42421376|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42588547|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42588547|Male|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|31|41939120|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41939120|Male|Choroid plexus|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|41911213|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41911213|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|42031490|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42031490|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|42186878|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42186878|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42421376|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42421376|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|42588547|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42588547|Male|Craniopharyngioma|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|41939120|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41939120|Male|Craniopharyngioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41911213|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42031490|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42186878|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42421376|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42588547|Male|Diffuse astrocytoma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41939120|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|290|41911213|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.7|0.7|Malignant|274|42031490|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|42186878|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42421376|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.7|Malignant|315|42588547|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|290|41939120|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42031490|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42031490|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42186878|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42186878|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42421376|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42421376|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|41939120|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41939120|Male|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41911213|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|105|42031490|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|42186878|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|42421376|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|42588547|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41939120|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|17|41911213|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41911213|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|20|42031490|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|85|42031490|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|26|42186878|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|99|42186878|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42421376|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|96|42421376|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42588547|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|114|42588547|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|41939120|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|95|41939120|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|41911213|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42031490|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|64|42186878|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42421376|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|42588547|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.2|Malignant|73|41939120|Male|Glioblastoma|2009|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|229|41911213|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.4|0.6|0.5|Malignant|215|42031490|Male|Glioma malignant, NOS|2005|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.5|Malignant|228|42186878|Male|Glioma malignant, NOS|2006|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.6|0.6|Malignant|235|42421376|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|248|42588547|Male|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.5|0.6|0.5|Malignant|229|41939120|Male|Glioma malignant, NOS|2009|0.5|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|18|41911213|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41911213|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42421376|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42421376|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|41911213|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41911213|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42031490|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42031490|Male|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|42186878|Male|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42186878|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42421376|Male|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42421376|Male|Hemangioma|2007|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|42588547|Male|Hemangioma|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42588547|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|41939120|Male|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41939120|Male|Hemangioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|41911213|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41911213|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42031490|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42031490|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42186878|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42186878|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|42421376|Male|Meningioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42421376|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42588547|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42588547|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|41939120|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41939120|Male|Meningioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Mixed glioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Mixed glioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Mixed glioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|41911213|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41911213|Male|Neoplasm, unspecified|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42031490|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42031490|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|49|42186878|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|42186878|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|60|42421376|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|42421376|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42588547|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|21|42588547|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|41939120|Male|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|29|41939120|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|119|41911213|Male|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41911213|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|104|42031490|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42031490|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42186878|Male|Nerve sheath, benign and malignant|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42186878|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42421376|Male|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42421376|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42588547|Male|Nerve sheath, benign and malignant|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42588547|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|41939120|Male|Nerve sheath, benign and malignant|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41939120|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Neuroepithelial|2009|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|41911213|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41911213|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|152|42031490|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|31|42031490|Male|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|151|42186878|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42186878|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42421376|Male|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42421376|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|163|42588547|Male|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42588547|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|143|41939120|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41939120|Male|Neuronal/glial, neuronal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|37|41911213|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|42031490|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|42186878|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42421376|Male|Oligodendroglioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|30|42588547|Male|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41939120|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41911213|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42031490|Male|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42031490|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42186878|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42186878|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42421376|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Other mesenchymal|2008|~|~|~
0-19|~|~|~|Malignant|~|42588547|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41939120|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41939120|Male|Other mesenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|362|41911213|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|338|42031490|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|352|42186878|Male|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|332|42421376|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|370|42588547|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.8|0.8|Malignant|317|41939120|Male|Pilocytic astrocytoma|2009|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|41911213|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41911213|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42031490|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42031490|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186878|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42186878|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42421376|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42421376|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42588547|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42588547|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41939120|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|41939120|Male|Pineal parenchymal|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|41911213|Male|Pituitary|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41911213|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|42031490|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42031490|Male|Pituitary|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42186878|Male|Pituitary|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42186878|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|107|42421376|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42421376|Male|Pituitary|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42588547|Male|Pituitary|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42588547|Male|Pituitary|2008|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|123|41939120|Male|Pituitary|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41939120|Male|Pituitary|2009|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|666|41911213|Male|Total|2004|1.5|1.7|1.6
0-19|3.3|3.7|3.5|Malignant|1476|41911213|Male|Total|2004|3.3|3.7|3.5
0-19|1.6|1.8|1.7|Benign/Borderline|711|42031490|Male|Total|2005|1.6|1.8|1.7
0-19|3.1|3.5|3.3|Malignant|1392|42031490|Male|Total|2005|3.1|3.5|3.3
0-19|1.6|1.9|1.7|Benign/Borderline|735|42186878|Male|Total|2006|1.6|1.9|1.7
0-19|3.3|3.7|3.5|Malignant|1474|42186878|Male|Total|2006|3.3|3.7|3.5
0-19|1.6|1.9|1.7|Benign/Borderline|740|42421376|Male|Total|2007|1.6|1.9|1.7
0-19|3.3|3.7|3.5|Malignant|1476|42421376|Male|Total|2007|3.3|3.7|3.5
0-19|1.6|1.8|1.7|Benign/Borderline|731|42588547|Male|Total|2008|1.6|1.8|1.7
0-19|3.4|3.8|3.6|Malignant|1540|42588547|Male|Total|2008|3.4|3.8|3.6
0-19|1.7|2.0|1.8|Benign/Borderline|761|41939120|Male|Total|2009|1.7|1.9|1.8
0-19|3.2|3.5|3.3|Malignant|1401|41939120|Male|Total|2009|3.2|3.5|3.3
0-19|0.2|0.3|0.3|Benign/Borderline|119|41911213|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41911213|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|104|42031490|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42031490|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42186878|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42186878|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42421376|Male|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42421376|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42588547|Male|Tumors of Cranial and Spinal Nerves|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42588547|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|41939120|Male|Tumors of Cranial and Spinal Nerves|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41939120|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|227|41911213|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.4|3.2|Malignant|1337|41911213|Male|Tumors of Neuroepthelial Tissue|2004|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|243|42031490|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.8|3.2|3.0|Malignant|1260|42031490|Male|Tumors of Neuroepthelial Tissue|2005|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|249|42186878|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1327|42186878|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|248|42421376|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1331|42421376|Male|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|250|42588547|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1379|42588547|Male|Tumors of Neuroepthelial Tissue|2008|3.1|3.4|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|233|41939120|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|2.8|3.1|3.0|Malignant|1253|41939120|Male|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.3|0.5|0.4|Benign/Borderline|162|41911213|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41911213|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|196|42031490|Male|Tumors of Sellar Region|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42031490|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|160|42186878|Male|Tumors of Sellar Region|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42186878|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|188|42421376|Male|Tumors of Sellar Region|2007|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42421376|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|202|42588547|Male|Tumors of Sellar Region|2008|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42588547|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|191|41939120|Male|Tumors of Sellar Region|2009|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41939120|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|41911213|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41911213|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|80|42031490|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42031490|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|80|42186878|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42186878|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|42421376|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42421376|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|42588547|Male|Tumors of the Meninges|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42588547|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41939120|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41939120|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|41911213|Male|Unclassified Tumors|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41911213|Male|Unclassified Tumors|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|42031490|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42031490|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|78|42186878|Male|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|42186878|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|98|42421376|Male|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|42421376|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|70|42588547|Male|Unclassified Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|42588547|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|123|41939120|Male|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|29|41939120|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|29|41911213|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41911213|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|42031490|Male|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42031490|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42186878|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|42186878|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|42421376|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|21|42421376|Male|Unique astrocytoma variants|2007|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|42588547|Male|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42588547|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|41939120|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|21|41939120|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81819970|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82072745|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82389800|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82856970|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83197604|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|81937898|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|81819970|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|57|82072745|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82389800|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|82|82856970|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|83197604|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|64|81937898|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81819970|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82072745|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82389800|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82856970|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83197604|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|81937898|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|190|81819970|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82072745|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|190|82389800|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.2|0.2|Malignant|179|82856970|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|176|83197604|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|176|81937898|Male and Female|Astrocytoma, NOS|2009|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|57|81819970|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81819970|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|82072745|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82072745|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82389800|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82389800|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|63|82856970|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82856970|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|73|83197604|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|83197604|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|51|81937898|Male and Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81937898|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|167|81819970|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81819970|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|160|82072745|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82072745|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|150|82389800|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82389800|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82856970|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82856970|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|148|83197604|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83197604|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|151|81937898|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81937898|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|81819970|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|41|82072745|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|82389800|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82856970|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|83197604|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81937898|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|505|81819970|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|457|82072745|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|495|82389800|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|82856970|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|545|83197604|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.5|0.6|0.6|Malignant|478|81937898|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81819970|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81819970|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82072745|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82072745|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82389800|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82389800|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|82856970|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82856970|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|83197604|Male and Female|Ependymoma variants|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83197604|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|29|81937898|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81937898|Male and Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|81819970|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|213|82072745|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|205|82389800|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|183|82856970|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|170|83197604|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|81937898|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|30|81819970|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|147|81819970|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|82072745|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82072745|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|40|82389800|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|123|82389800|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|31|82856970|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82856970|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|83197604|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|141|83197604|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|40|81937898|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|136|81937898|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|125|81819970|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82072745|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|108|82389800|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|82856970|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|83197604|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|112|81937898|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|455|81819970|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|436|82072745|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|82389800|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.6|0.6|Malignant|482|82856970|Male and Female|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|499|83197604|Male and Female|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.5|0.6|0.6|Malignant|486|81937898|Male and Female|Glioma malignant, NOS|2009|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|81819970|Male and Female|Hemangioblastoma|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81819970|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|82072745|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82072745|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|21|82389800|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82389800|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82856970|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82856970|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|20|83197604|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83197604|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|81937898|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81937898|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81819970|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81819970|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82072745|Male and Female|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82072745|Male and Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|82389800|Male and Female|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82389800|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|82856970|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82856970|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|65|83197604|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83197604|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|82|81937898|Male and Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81937898|Male and Female|Hemangioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81819970|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82072745|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82389800|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82856970|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83197604|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|81937898|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81819970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82072745|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82389800|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82856970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83197604|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81937898|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|89|81819970|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81819970|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|82072745|Male and Female|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82072745|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82389800|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82389800|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82856970|Male and Female|Meningioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82856970|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|83197604|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83197604|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|111|81937898|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81937898|Male and Female|Meningioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81819970|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|82072745|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82389800|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82856970|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83197604|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|81937898|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|81|81819970|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|39|81819970|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|102|82072745|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|37|82072745|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|95|82389800|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82389800|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|108|82856970|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|42|82856970|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|103|83197604|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|40|83197604|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|134|81937898|Male and Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|45|81937898|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|219|81819970|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81819970|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|241|82072745|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82072745|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|273|82389800|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82389800|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|221|82856970|Male and Female|Nerve sheath, benign and malignant|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82856970|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|227|83197604|Male and Female|Nerve sheath, benign and malignant|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83197604|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|204|81937898|Male and Female|Nerve sheath, benign and malignant|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|81937898|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81819970|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82072745|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82389800|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82856970|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83197604|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|81937898|Male and Female|Neuroepithelial|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|269|81819970|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|81819970|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|284|82072745|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|57|82072745|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|267|82389800|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82389800|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|288|82856970|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|60|82856970|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|289|83197604|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|54|83197604|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|266|81937898|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|26|81937898|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|60|81819970|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|82072745|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|51|82389800|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|82856970|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|46|83197604|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|81937898|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81819970|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81819970|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82072745|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82072745|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82389800|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82389800|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82856970|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82856970|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|30|83197604|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83197604|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|81937898|Male and Female|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81937898|Male and Female|Other mesenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.8|Malignant|682|81819970|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|653|82072745|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|658|82389800|Male and Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|655|82856970|Male and Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.8|Malignant|690|83197604|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.7|0.8|0.8|Malignant|626|81937898|Male and Female|Pilocytic astrocytoma|2009|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|81819970|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|81819970|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82072745|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82072745|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82389800|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82389800|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82856970|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82856970|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83197604|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|83197604|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81937898|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|81937898|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|327|81819970|Male and Female|Pituitary|2004|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|81819970|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|371|82072745|Male and Female|Pituitary|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82072745|Male and Female|Pituitary|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|369|82389800|Male and Female|Pituitary|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|82389800|Male and Female|Pituitary|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|380|82856970|Male and Female|Pituitary|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82856970|Male and Female|Pituitary|2007|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|405|83197604|Male and Female|Pituitary|2008|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|83197604|Male and Female|Pituitary|2008|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|382|81937898|Male and Female|Pituitary|2009|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|81937898|Male and Female|Pituitary|2009|~|~|~
0-19|1.6|1.8|1.7|Benign/Borderline|1424|81819970|Male and Female|Total|2004|1.7|1.8|1.7
0-19|3.2|3.5|3.4|Malignant|2747|81819970|Male and Female|Total|2004|3.2|3.5|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|1550|82072745|Male and Female|Total|2005|1.8|2.0|1.9
0-19|3.0|3.3|3.2|Malignant|2589|82072745|Male and Female|Total|2005|3.0|3.3|3.2
0-19|1.8|2.0|1.9|Benign/Borderline|1566|82389800|Male and Female|Total|2006|1.8|2.0|1.9
0-19|3.1|3.4|3.2|Malignant|2665|82389800|Male and Female|Total|2006|3.1|3.4|3.2
0-19|1.8|2.0|1.9|Benign/Borderline|1592|82856970|Male and Female|Total|2007|1.8|2.0|1.9
0-19|3.2|3.4|3.3|Malignant|2739|82856970|Male and Female|Total|2007|3.2|3.4|3.3
0-19|1.8|2.0|1.9|Benign/Borderline|1597|83197604|Male and Female|Total|2008|1.8|2.0|1.9
0-19|3.2|3.4|3.3|Malignant|2768|83197604|Male and Female|Total|2008|3.2|3.5|3.3
0-19|1.8|2.0|1.9|Benign/Borderline|1578|81937898|Male and Female|Total|2009|1.8|2.0|1.9
0-19|3.0|3.2|3.1|Malignant|2559|81937898|Male and Female|Total|2009|3.0|3.2|3.1
0-19|0.2|0.3|0.3|Benign/Borderline|219|81819970|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81819970|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|241|82072745|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82072745|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|273|82389800|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82389800|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|221|82856970|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82856970|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|227|83197604|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83197604|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|204|81937898|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|81937898|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|418|81819970|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.2|3.1|Malignant|2515|81819970|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.2|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|429|82072745|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.8|3.0|2.9|Malignant|2368|82072745|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.0|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|440|82389800|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
0-19|2.9|3.1|3.0|Malignant|2450|82389800|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|462|82856970|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|2524|82856970|Male and Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|454|83197604|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.9|3.2|3.1|Malignant|2551|83197604|Male and Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|416|81937898|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.7|3.0|2.8|Malignant|2333|81937898|Male and Female|Tumors of Neuroepthelial Tissue|2009|2.7|3.0|2.8
0-19|0.6|0.7|0.6|Benign/Borderline|494|81819970|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81819970|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|531|82072745|Male and Female|Tumors of Sellar Region|2005|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|82072745|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|519|82389800|Male and Female|Tumors of Sellar Region|2006|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|82389800|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|552|82856970|Male and Female|Tumors of Sellar Region|2007|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82856970|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|553|83197604|Male and Female|Tumors of Sellar Region|2008|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83197604|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|533|81937898|Male and Female|Tumors of Sellar Region|2009|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|81937898|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|143|81819970|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|81819970|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|173|82072745|Male and Female|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|82072745|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|149|82389800|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82389800|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|158|82856970|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|18|82856970|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|160|83197604|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83197604|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|169|81937898|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|21|81937898|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|119|81819970|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|39|81819970|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|142|82072745|Male and Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|82072745|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|145|82389800|Male and Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82389800|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|168|82856970|Male and Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82856970|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|168|83197604|Male and Female|Unclassified Tumors|2008|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|42|83197604|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|216|81937898|Male and Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|47|81937898|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|47|81819970|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81819970|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|82072745|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82072745|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|47|82389800|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82389800|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82856970|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|54|82856970|Male and Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|47|83197604|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|83197604|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|81937898|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|81937898|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|108999308|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|108999308|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110151129|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110151129|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111329588|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111329588|Female|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|112532199|Female|All other|2007|~|~|~
20+|~|~|~|Malignant|~|112532199|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|113691563|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|113691563|Female|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|112712574|Female|All other|2009|~|~|~
20+|~|~|~|Malignant|~|112712574|Female|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.5|0.5|Malignant|554|108999308|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110151129|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|505|110151129|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111329588|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|490|111329588|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112532199|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|523|112532199|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113691563|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|490|113691563|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112712574|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|465|112712574|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108999308|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|178|108999308|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110151129|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|162|110151129|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111329588|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|131|111329588|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112532199|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|150|112532199|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113691563|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|163|113691563|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112712574|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|136|112712574|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108999308|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|108999308|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110151129|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|557|110151129|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111329588|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|525|111329588|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112532199|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|523|112532199|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113691563|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|480|113691563|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112712574|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|443|112712574|Female|Astrocytoma, NOS|2009|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|108999308|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108999308|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|110151129|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110151129|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|40|111329588|Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111329588|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|54|112532199|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112532199|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|113691563|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|113691563|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|41|112712574|Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112712574|Female|Choroid plexus|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|194|108999308|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108999308|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|177|110151129|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110151129|Female|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|189|111329588|Female|Craniopharyngioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|111329588|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|212|112532199|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112532199|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|209|113691563|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113691563|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|205|112712574|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112712574|Female|Craniopharyngioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|108999308|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110151129|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|129|110151129|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111329588|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111329588|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112532199|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|129|112532199|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113691563|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|135|113691563|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112712574|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|151|112712574|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108999308|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.0|0.1|0.1|Malignant|67|108999308|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110151129|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110151129|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111329588|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|75|111329588|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112532199|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112532199|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113691563|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|85|113691563|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112712574|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|102|112712574|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|104|108999308|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|108999308|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|110151129|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110151129|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|111329588|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111329588|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|109|112532199|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112532199|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|106|113691563|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|113691563|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|102|112712574|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112712574|Female|Ependymoma variants|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|289|108999308|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110151129|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|296|110151129|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111329588|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|290|111329588|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112532199|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|288|112532199|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113691563|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|306|113691563|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112712574|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|319|112712574|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|20|108999308|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108999308|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110151129|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110151129|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|111329588|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111329588|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|112532199|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112532199|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|113691563|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113691563|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|112712574|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112712574|Female|Germ Cell Tumors|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4070|108999308|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110151129|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4120|110151129|Female|Glioblastoma|2005|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|111329588|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.6|3.5|Malignant|4257|111329588|Female|Glioblastoma|2006|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|112532199|Female|Glioblastoma|2007|~|~|~
20+|3.4|3.6|3.5|Malignant|4336|112532199|Female|Glioblastoma|2007|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|113691563|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4379|113691563|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|112712574|Female|Glioblastoma|2009|~|~|~
20+|3.3|3.5|3.4|Malignant|4278|112712574|Female|Glioblastoma|2009|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|108999308|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|419|108999308|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110151129|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|384|110151129|Female|Glioma malignant, NOS|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111329588|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|388|111329588|Female|Glioma malignant, NOS|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112532199|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|404|112532199|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|113691563|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|421|113691563|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112712574|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|459|112712574|Female|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|209|108999308|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108999308|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|219|110151129|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110151129|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|211|111329588|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111329588|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|112532199|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112532199|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|113691563|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113691563|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|207|112712574|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112712574|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|234|108999308|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108999308|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|255|110151129|Female|Hemangioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110151129|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|274|111329588|Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|111329588|Female|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|320|112532199|Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|112532199|Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|397|113691563|Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|113691563|Female|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|427|112712574|Female|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|112712574|Female|Hemangioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|25|108999308|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110151129|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110151129|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111329588|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|19|111329588|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112532199|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|24|112532199|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113691563|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|113691563|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112712574|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112712574|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108999308|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|587|108999308|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110151129|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|654|110151129|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111329588|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|668|111329588|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|112532199|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|628|112532199|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|113691563|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|689|113691563|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112712574|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|627|112712574|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|11.7|12.1|11.9|Benign/Borderline|13861|108999308|Female|Meningioma|2004|12.5|12.9|12.7
20+|0.2|0.3|0.2|Malignant|281|108999308|Female|Meningioma|2004|0.2|0.3|0.3
20+|12.5|12.9|12.7|Benign/Borderline|15066|110151129|Female|Meningioma|2005|13.5|13.9|13.7
20+|0.2|0.3|0.2|Malignant|273|110151129|Female|Meningioma|2005|0.2|0.3|0.2
20+|12.9|13.4|13.2|Benign/Borderline|15852|111329588|Female|Meningioma|2006|14.0|14.5|14.2
20+|0.2|0.2|0.2|Malignant|246|111329588|Female|Meningioma|2006|0.2|0.3|0.2
20+|13.2|13.6|13.4|Benign/Borderline|16367|112532199|Female|Meningioma|2007|14.3|14.8|14.5
20+|0.2|0.2|0.2|Malignant|258|112532199|Female|Meningioma|2007|0.2|0.3|0.2
20+|13.5|13.9|13.7|Benign/Borderline|17084|113691563|Female|Meningioma|2008|14.8|15.3|15.0
20+|0.1|0.2|0.2|Malignant|202|113691563|Female|Meningioma|2008|0.2|0.2|0.2
20+|13.8|14.3|14.0|Benign/Borderline|17470|112712574|Female|Meningioma|2009|15.3|15.7|15.5
20+|0.1|0.2|0.2|Malignant|193|112712574|Female|Meningioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108999308|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|192|108999308|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110151129|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|231|110151129|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111329588|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|265|111329588|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112532199|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|231|112532199|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113691563|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|254|113691563|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112712574|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.2|Malignant|259|112712574|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|0.6|0.7|0.6|Benign/Borderline|765|108999308|Female|Neoplasm, unspecified|2004|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|695|108999308|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|818|110151129|Female|Neoplasm, unspecified|2005|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|711|110151129|Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|765|111329588|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.5|0.6|0.6|Malignant|719|111329588|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|784|112532199|Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|642|112532199|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|774|113691563|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|738|113691563|Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|802|112712574|Female|Neoplasm, unspecified|2009|0.7|0.8|0.7
20+|0.5|0.6|0.5|Malignant|704|112712574|Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|2.2|2.4|2.3|Benign/Borderline|2546|108999308|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|21|108999308|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2632|110151129|Female|Nerve sheath, benign and malignant|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|110151129|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2733|111329588|Female|Nerve sheath, benign and malignant|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|22|111329588|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2689|112532199|Female|Nerve sheath, benign and malignant|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|41|112532199|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2682|113691563|Female|Nerve sheath, benign and malignant|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|113691563|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2591|112712574|Female|Nerve sheath, benign and malignant|2009|2.2|2.4|2.3
20+|~|~|~|Malignant|~|112712574|Female|Nerve sheath, benign and malignant|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|108999308|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108999308|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110151129|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|21|110151129|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111329588|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111329588|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112532199|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|19|112532199|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113691563|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|25|113691563|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112712574|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|112712574|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|155|108999308|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108999308|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|177|110151129|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|110151129|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|111329588|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111329588|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|194|112532199|Female|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|112532199|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|192|113691563|Female|Neuronal/glial, neuronal|2008|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|113691563|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|197|112712574|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|112712574|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108999308|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|337|108999308|Female|Oligodendroglioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110151129|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|343|110151129|Female|Oligodendroglioma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111329588|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|370|111329588|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112532199|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|359|112532199|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113691563|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|340|113691563|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112712574|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|330|112712574|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|71|108999308|Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|108999308|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|110151129|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110151129|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|79|111329588|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|111329588|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|112532199|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|112532199|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|101|113691563|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|49|113691563|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112712574|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|112712574|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108999308|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|121|108999308|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110151129|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|148|110151129|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111329588|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111329588|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112532199|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|157|112532199|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113691563|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|113691563|Female|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112712574|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|122|112712574|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|108999308|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|108999308|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|110151129|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110151129|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|111329588|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111329588|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|112532199|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|112532199|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|40|113691563|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|113691563|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|112712574|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|112712574|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3776|108999308|Female|Pituitary|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|26|108999308|Female|Pituitary|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|4159|110151129|Female|Pituitary|2005|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|23|110151129|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.0|4.3|4.1|Benign/Borderline|4586|111329588|Female|Pituitary|2006|4.0|4.2|4.1
20+|~|~|~|Malignant|~|111329588|Female|Pituitary|2006|~|~|~
20+|4.0|4.2|4.1|Benign/Borderline|4606|112532199|Female|Pituitary|2007|4.0|4.2|4.1
20+|~|~|~|Malignant|~|112532199|Female|Pituitary|2007|~|~|~
20+|4.2|4.4|4.3|Benign/Borderline|4828|113691563|Female|Pituitary|2008|4.1|4.4|4.2
20+|~|~|~|Malignant|~|113691563|Female|Pituitary|2008|~|~|~
20+|4.3|4.6|4.4|Benign/Borderline|4986|112712574|Female|Pituitary|2009|4.3|4.5|4.4
20+|~|~|~|Malignant|~|112712574|Female|Pituitary|2009|~|~|~
20+|19.1|19.6|19.3|Benign/Borderline|22056|108999308|Female|Total|2004|20.0|20.5|20.2
20+|7.4|7.7|7.5|Malignant|8655|108999308|Female|Total|2004|7.8|8.1|7.9
20+|20.3|20.9|20.6|Benign/Borderline|23866|110151129|Female|Total|2005|21.4|21.9|21.7
20+|7.4|7.7|7.5|Malignant|8790|110151129|Female|Total|2005|7.8|8.1|8.0
20+|21.2|21.7|21.4|Benign/Borderline|25186|111329588|Female|Total|2006|22.3|22.9|22.6
20+|7.4|7.7|7.5|Malignant|8855|111329588|Female|Total|2006|7.8|8.1|8.0
20+|21.3|21.8|21.6|Benign/Borderline|25751|112532199|Female|Total|2007|22.6|23.2|22.9
20+|7.3|7.6|7.5|Malignant|8922|112532199|Female|Total|2007|7.8|8.1|7.9
20+|21.8|22.4|22.1|Benign/Borderline|26797|113691563|Female|Total|2008|23.3|23.9|23.6
20+|7.3|7.6|7.4|Malignant|9048|113691563|Female|Total|2008|7.8|8.1|8.0
20+|22.3|22.8|22.6|Benign/Borderline|27261|112712574|Female|Total|2009|23.9|24.5|24.2
20+|7.1|7.4|7.2|Malignant|8769|112712574|Female|Total|2009|7.6|7.9|7.8
20+|2.2|2.4|2.3|Benign/Borderline|2546|108999308|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|21|108999308|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2635|110151129|Female|Tumors of Cranial and Spinal Nerves|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|110151129|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2734|111329588|Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|22|111329588|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2690|112532199|Female|Tumors of Cranial and Spinal Nerves|2007|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|41|112532199|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2684|113691563|Female|Tumors of Cranial and Spinal Nerves|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|113691563|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2594|112712574|Female|Tumors of Cranial and Spinal Nerves|2009|2.2|2.4|2.3
20+|~|~|~|Malignant|~|112712574|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|376|108999308|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.1|Malignant|6974|108999308|Female|Tumors of Neuroepthelial Tissue|2004|6.2|6.6|6.4
20+|0.3|0.4|0.4|Benign/Borderline|419|110151129|Female|Tumors of Neuroepthelial Tissue|2005|0.3|0.4|0.4
20+|6.0|6.3|6.1|Malignant|7043|110151129|Female|Tumors of Neuroepthelial Tissue|2005|6.2|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|457|111329588|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.4|0.4
20+|6.0|6.2|6.1|Malignant|7121|111329588|Female|Tumors of Neuroepthelial Tissue|2006|6.2|6.5|6.4
20+|0.4|0.4|0.4|Benign/Borderline|459|112532199|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.4|0.4
20+|6.0|6.3|6.1|Malignant|7278|112532199|Female|Tumors of Neuroepthelial Tissue|2007|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|455|113691563|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.4|0.4
20+|5.9|6.2|6.1|Malignant|7292|113691563|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|452|112712574|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.4|0.4
20+|5.8|6.1|5.9|Malignant|7161|112712574|Female|Tumors of Neuroepthelial Tissue|2009|6.2|6.5|6.4
20+|3.5|3.8|3.6|Benign/Borderline|3970|108999308|Female|Tumors of Sellar Region|2004|3.5|3.8|3.6
20+|0.0|0.0|0.0|Malignant|26|108999308|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.1|3.9|Benign/Borderline|4336|110151129|Female|Tumors of Sellar Region|2005|3.8|4.1|3.9
20+|0.0|0.0|0.0|Malignant|23|110151129|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4775|111329588|Female|Tumors of Sellar Region|2006|4.2|4.4|4.3
20+|~|~|~|Malignant|~|111329588|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.2|4.4|4.3|Benign/Borderline|4818|112532199|Female|Tumors of Sellar Region|2007|4.2|4.4|4.3
20+|~|~|~|Malignant|~|112532199|Female|Tumors of Sellar Region|2007|~|~|~
20+|4.3|4.6|4.5|Benign/Borderline|5037|113691563|Female|Tumors of Sellar Region|2008|4.3|4.6|4.4
20+|~|~|~|Malignant|~|113691563|Female|Tumors of Sellar Region|2008|~|~|~
20+|4.5|4.8|4.6|Benign/Borderline|5191|112712574|Female|Tumors of Sellar Region|2009|4.5|4.7|4.6
20+|~|~|~|Malignant|~|112712574|Female|Tumors of Sellar Region|2009|~|~|~
20+|12.0|12.4|12.2|Benign/Borderline|14141|108999308|Female|Tumors of the Meninges|2004|12.8|13.2|13.0
20+|0.2|0.3|0.3|Malignant|306|108999308|Female|Tumors of the Meninges|2004|0.3|0.3|0.3
20+|12.8|13.2|13.0|Benign/Borderline|15362|110151129|Female|Tumors of the Meninges|2005|13.7|14.2|13.9
20+|0.2|0.3|0.3|Malignant|300|110151129|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|13.2|13.6|13.4|Benign/Borderline|16142|111329588|Female|Tumors of the Meninges|2006|14.3|14.7|14.5
20+|0.2|0.3|0.2|Malignant|274|111329588|Female|Tumors of the Meninges|2006|0.2|0.3|0.2
20+|13.4|13.8|13.6|Benign/Borderline|16644|112532199|Female|Tumors of the Meninges|2007|14.6|15.0|14.8
20+|0.2|0.3|0.2|Malignant|292|112532199|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|13.8|14.2|14.0|Benign/Borderline|17412|113691563|Female|Tumors of the Meninges|2008|15.1|15.5|15.3
20+|0.2|0.2|0.2|Malignant|251|113691563|Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|14.1|14.5|14.3|Benign/Borderline|17760|112712574|Female|Tumors of the Meninges|2009|15.5|16.0|15.8
20+|0.2|0.2|0.2|Malignant|217|112712574|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|0.8|0.9|0.9|Benign/Borderline|1002|108999308|Female|Unclassified Tumors|2004|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|702|108999308|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1076|110151129|Female|Unclassified Tumors|2005|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|717|110151129|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.8|0.9|0.9|Benign/Borderline|1046|111329588|Female|Unclassified Tumors|2006|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|724|111329588|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1108|112532199|Female|Unclassified Tumors|2007|0.9|1.0|1.0
20+|0.5|0.5|0.5|Malignant|646|112532199|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1177|113691563|Female|Unclassified Tumors|2008|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|751|113691563|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.0|1.1|1.0|Benign/Borderline|1230|112712574|Female|Unclassified Tumors|2009|1.0|1.2|1.1
20+|0.5|0.6|0.5|Malignant|712|112712574|Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|0.0|0.1|0.0|Benign/Borderline|52|108999308|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|108999308|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|38|110151129|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|110151129|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|111329588|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111329588|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|57|112532199|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112532199|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|51|113691563|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|19|113691563|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|61|112712574|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|112712574|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|102226461|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103529277|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103529277|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|19|104873824|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104873824|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|106190726|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|106190726|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|107485679|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107485679|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|106701304|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|106701304|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|102226461|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|659|102226461|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103529277|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|674|103529277|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104873824|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|680|104873824|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106190726|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|653|106190726|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|107485679|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|698|107485679|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106701304|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|667|106701304|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|102226461|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|102226461|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103529277|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|192|103529277|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104873824|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|209|104873824|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106190726|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|175|106190726|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|107485679|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|182|107485679|Male|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106701304|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|170|106701304|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|102226461|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|637|102226461|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103529277|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|632|103529277|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104873824|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|647|104873824|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106190726|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.6|0.6|Malignant|619|106190726|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|107485679|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|604|107485679|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106701304|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.5|0.5|Malignant|531|106701304|Male|Astrocytoma, NOS|2009|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|22|102226461|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|102226461|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|103529277|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103529277|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|104873824|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104873824|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|106190726|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106190726|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|107485679|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107485679|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|106701304|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106701304|Male|Choroid plexus|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|185|102226461|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|102226461|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|103529277|Male|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103529277|Male|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|104873824|Male|Craniopharyngioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104873824|Male|Craniopharyngioma|2006|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|183|106190726|Male|Craniopharyngioma|2007|0.1|0.2|0.2
20+|~|~|~|Malignant|~|106190726|Male|Craniopharyngioma|2007|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|187|107485679|Male|Craniopharyngioma|2008|0.1|0.2|0.2
20+|~|~|~|Malignant|~|107485679|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|186|106701304|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106701304|Male|Craniopharyngioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|102226461|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|141|102226461|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103529277|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|149|103529277|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104873824|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|199|104873824|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106190726|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|175|106190726|Male|Diffuse astrocytoma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|107485679|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|200|107485679|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106701304|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|190|106701304|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|102226461|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|95|102226461|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103529277|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103529277|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104873824|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|90|104873824|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106190726|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|125|106190726|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|107485679|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|107485679|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106701304|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|122|106701304|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|146|102226461|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|102226461|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|144|103529277|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103529277|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|104873824|Male|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|104873824|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|137|106190726|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106190726|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|139|107485679|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|107485679|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|129|106701304|Male|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|106701304|Male|Ependymoma variants|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|102226461|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|291|102226461|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103529277|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|294|103529277|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104873824|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|281|104873824|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106190726|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|278|106190726|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|107485679|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|308|107485679|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106701304|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|311|106701304|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|23|102226461|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|102226461|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|103529277|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|52|103529277|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|104873824|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104873824|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|106190726|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|75|106190726|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|107485679|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|107485679|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|106701304|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|106701304|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5457|102226461|Male|Glioblastoma|2004|5.2|5.5|5.3
20+|~|~|~|Benign/Borderline|~|103529277|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.6|Malignant|5489|103529277|Male|Glioblastoma|2005|5.2|5.4|5.3
20+|~|~|~|Benign/Borderline|~|104873824|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5479|104873824|Male|Glioblastoma|2006|5.1|5.4|5.2
20+|~|~|~|Benign/Borderline|~|106190726|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5769|106190726|Male|Glioblastoma|2007|5.3|5.6|5.4
20+|~|~|~|Benign/Borderline|~|107485679|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5936|107485679|Male|Glioblastoma|2008|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|106701304|Male|Glioblastoma|2009|~|~|~
20+|5.3|5.6|5.4|Malignant|5720|106701304|Male|Glioblastoma|2009|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|102226461|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|427|102226461|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103529277|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|448|103529277|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104873824|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|444|104873824|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106190726|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|452|106190726|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|107485679|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|454|107485679|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106701304|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|415|106701304|Male|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|0.2|0.3|0.2|Benign/Borderline|249|102226461|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|102226461|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|273|103529277|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103529277|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|273|104873824|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104873824|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|245|106190726|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|106190726|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|280|107485679|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|107485679|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|248|106701304|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|106701304|Male|Hemangioblastoma|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|130|102226461|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|102226461|Male|Hemangioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|176|103529277|Male|Hemangioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|103529277|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|104873824|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104873824|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|241|106190726|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|106190726|Male|Hemangioma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|293|107485679|Male|Hemangioma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|107485679|Male|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|359|106701304|Male|Hemangioma|2009|0.3|0.4|0.3
20+|~|~|~|Malignant|~|106701304|Male|Hemangioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|102226461|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|25|102226461|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103529277|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|25|103529277|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104873824|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|34|104873824|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106190726|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|21|106190726|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107485679|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|31|107485679|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106701304|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|106701304|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|740|102226461|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103529277|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|761|103529277|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|104873824|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|750|104873824|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|106190726|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|726|106190726|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|107485679|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.7|Malignant|763|107485679|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|106701304|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|716|106701304|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.7
20+|5.0|5.3|5.2|Benign/Borderline|4842|102226461|Male|Meningioma|2004|4.6|4.9|4.7
20+|0.2|0.2|0.2|Malignant|172|102226461|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.3|5.6|5.4|Benign/Borderline|5172|103529277|Male|Meningioma|2005|4.9|5.1|5.0
20+|0.1|0.2|0.2|Malignant|157|103529277|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.5|5.8|5.7|Benign/Borderline|5507|104873824|Male|Meningioma|2006|5.1|5.4|5.3
20+|0.1|0.2|0.2|Malignant|149|104873824|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.5|5.8|5.7|Benign/Borderline|5620|106190726|Male|Meningioma|2007|5.2|5.4|5.3
20+|0.1|0.2|0.2|Malignant|174|106190726|Male|Meningioma|2007|0.1|0.2|0.2
20+|5.8|6.1|6.0|Benign/Borderline|6030|107485679|Male|Meningioma|2008|5.5|5.8|5.6
20+|0.1|0.2|0.1|Malignant|144|107485679|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.0|6.3|6.2|Benign/Borderline|6192|106701304|Male|Meningioma|2009|5.7|5.9|5.8
20+|0.1|0.2|0.1|Malignant|129|106701304|Male|Meningioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|102226461|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|281|102226461|Male|Mixed glioma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103529277|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|321|103529277|Male|Mixed glioma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104873824|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|354|104873824|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106190726|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|336|106190726|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|107485679|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|317|107485679|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106701304|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|359|106701304|Male|Mixed glioma|2009|0.3|0.4|0.3
20+|0.6|0.7|0.6|Benign/Borderline|550|102226461|Male|Neoplasm, unspecified|2004|0.5|0.6|0.5
20+|0.6|0.7|0.7|Malignant|611|102226461|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|602|103529277|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|595|103529277|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|588|104873824|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|568|104873824|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|560|106190726|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|571|106190726|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|570|107485679|Male|Neoplasm, unspecified|2008|0.5|0.6|0.5
20+|0.6|0.7|0.7|Malignant|621|107485679|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|542|106701304|Male|Neoplasm, unspecified|2009|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|593|106701304|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|2.2|2.4|2.3|Benign/Borderline|2300|102226461|Male|Nerve sheath, benign and malignant|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|102226461|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2514|103529277|Male|Nerve sheath, benign and malignant|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|29|103529277|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2459|104873824|Male|Nerve sheath, benign and malignant|2006|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|18|104873824|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2476|106190726|Male|Nerve sheath, benign and malignant|2007|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|106190726|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2409|107485679|Male|Nerve sheath, benign and malignant|2008|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|24|107485679|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2301|106701304|Male|Nerve sheath, benign and malignant|2009|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|19|106701304|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|102226461|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103529277|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103529277|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104873824|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|24|104873824|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106190726|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|31|106190726|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107485679|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|107485679|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106701304|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|19|106701304|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|158|102226461|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|102226461|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|179|103529277|Male|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|32|103529277|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|181|104873824|Male|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104873824|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|175|106190726|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106190726|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|200|107485679|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|107485679|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|106701304|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|106701304|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|456|102226461|Male|Oligodendroglioma|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103529277|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|420|103529277|Male|Oligodendroglioma|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|104873824|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|440|104873824|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106190726|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|418|106190726|Male|Oligodendroglioma|2007|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|107485679|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|386|107485679|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106701304|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|434|106701304|Male|Oligodendroglioma|2009|0.4|0.4|0.4
20+|0.1|0.1|0.1|Benign/Borderline|83|102226461|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|102226461|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|67|103529277|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|103529277|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|64|104873824|Male|Other mesenchymal|2006|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|104873824|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|106190726|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|106190726|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|107485679|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|107485679|Male|Other mesenchymal|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|91|106701304|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|106701304|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|102226461|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|148|102226461|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103529277|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103529277|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104873824|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|154|104873824|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106190726|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|141|106190726|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|107485679|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|146|107485679|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106701304|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|127|106701304|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|102226461|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|102226461|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103529277|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103529277|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|104873824|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|104873824|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106190726|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|16|106190726|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|107485679|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|107485679|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106701304|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|17|106701304|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|3.1|3.4|3.3|Benign/Borderline|3222|102226461|Male|Pituitary|2004|3.0|3.3|3.2
20+|0.0|0.0|0.0|Malignant|18|102226461|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.3|3.5|3.4|Benign/Borderline|3423|103529277|Male|Pituitary|2005|3.2|3.4|3.3
20+|~|~|~|Malignant|~|103529277|Male|Pituitary|2005|~|~|~
20+|3.5|3.7|3.6|Benign/Borderline|3661|104873824|Male|Pituitary|2006|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|18|104873824|Male|Pituitary|2006|0.0|0.0|0.0
20+|3.6|3.9|3.8|Benign/Borderline|3923|106190726|Male|Pituitary|2007|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|25|106190726|Male|Pituitary|2007|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|4243|107485679|Male|Pituitary|2008|3.8|4.1|3.9
20+|~|~|~|Malignant|~|107485679|Male|Pituitary|2008|~|~|~
20+|3.9|4.1|4.0|Benign/Borderline|4216|106701304|Male|Pituitary|2009|3.8|4.1|4.0
20+|~|~|~|Malignant|~|106701304|Male|Pituitary|2009|~|~|~
20+|12.2|12.6|12.4|Benign/Borderline|12034|102226461|Male|Total|2004|11.6|12.0|11.8
20+|10.6|11.0|10.8|Malignant|10543|102226461|Male|Total|2004|10.1|10.5|10.3
20+|12.9|13.4|13.2|Benign/Borderline|12975|103529277|Male|Total|2005|12.3|12.8|12.5
20+|10.6|11.0|10.8|Malignant|10645|103529277|Male|Total|2005|10.1|10.5|10.3
20+|13.2|13.7|13.4|Benign/Borderline|13500|104873824|Male|Total|2006|12.7|13.1|12.9
20+|10.4|10.8|10.6|Malignant|10697|104873824|Male|Total|2006|10.0|10.4|10.2
20+|13.3|13.8|13.5|Benign/Borderline|13858|106190726|Male|Total|2007|12.8|13.3|13.1
20+|10.4|10.8|10.6|Malignant|10901|106190726|Male|Total|2007|10.1|10.5|10.3
20+|13.9|14.3|14.1|Benign/Borderline|14679|107485679|Male|Total|2008|13.4|13.9|13.7
20+|10.4|10.8|10.6|Malignant|11151|107485679|Male|Total|2008|10.2|10.6|10.4
20+|13.9|14.4|14.2|Benign/Borderline|14686|106701304|Male|Total|2009|13.5|14.0|13.8
20+|10.0|10.4|10.2|Malignant|10717|106701304|Male|Total|2009|9.9|10.2|10.0
20+|2.2|2.4|2.3|Benign/Borderline|2300|102226461|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|102226461|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2514|103529277|Male|Tumors of Cranial and Spinal Nerves|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|29|103529277|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2460|104873824|Male|Tumors of Cranial and Spinal Nerves|2006|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|18|104873824|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2477|106190726|Male|Tumors of Cranial and Spinal Nerves|2007|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|106190726|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2411|107485679|Male|Tumors of Cranial and Spinal Nerves|2008|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|24|107485679|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.1|2.2|2.1|Benign/Borderline|2303|106701304|Male|Tumors of Cranial and Spinal Nerves|2009|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|19|106701304|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|446|102226461|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.8|9.2|9.0|Malignant|8877|102226461|Male|Tumors of Neuroepthelial Tissue|2004|8.5|8.9|8.7
20+|0.4|0.5|0.5|Benign/Borderline|500|103529277|Male|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|8.8|9.2|9.0|Malignant|8968|103529277|Male|Tumors of Neuroepthelial Tissue|2005|8.5|8.8|8.7
20+|0.4|0.5|0.5|Benign/Borderline|519|104873824|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|8.7|9.1|8.9|Malignant|9073|104873824|Male|Tumors of Neuroepthelial Tissue|2006|8.5|8.8|8.7
20+|0.4|0.5|0.5|Benign/Borderline|496|106190726|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.7|9.1|8.9|Malignant|9244|106190726|Male|Tumors of Neuroepthelial Tissue|2007|8.5|8.9|8.7
20+|0.5|0.5|0.5|Benign/Borderline|540|107485679|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|8.8|9.1|8.9|Malignant|9457|107485679|Male|Tumors of Neuroepthelial Tissue|2008|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|520|106701304|Male|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
20+|8.5|8.9|8.7|Malignant|9142|106701304|Male|Tumors of Neuroepthelial Tissue|2009|8.4|8.7|8.6
20+|3.3|3.6|3.4|Benign/Borderline|3407|102226461|Male|Tumors of Sellar Region|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|18|102226461|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|3645|103529277|Male|Tumors of Sellar Region|2005|3.4|3.6|3.5
20+|~|~|~|Malignant|~|103529277|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.6|3.9|3.8|Benign/Borderline|3843|104873824|Male|Tumors of Sellar Region|2006|3.5|3.8|3.7
20+|0.0|0.0|0.0|Malignant|19|104873824|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|3.8|4.1|3.9|Benign/Borderline|4106|106190726|Male|Tumors of Sellar Region|2007|3.7|4.0|3.9
20+|0.0|0.0|0.0|Malignant|25|106190726|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|4430|107485679|Male|Tumors of Sellar Region|2008|4.0|4.2|4.1
20+|~|~|~|Malignant|~|107485679|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.0|4.3|4.2|Benign/Borderline|4402|106701304|Male|Tumors of Sellar Region|2009|4.0|4.2|4.1
20+|~|~|~|Malignant|~|106701304|Male|Tumors of Sellar Region|2009|~|~|~
20+|5.3|5.6|5.5|Benign/Borderline|5174|102226461|Male|Tumors of the Meninges|2004|4.9|5.2|5.1
20+|0.2|0.2|0.2|Malignant|197|102226461|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.6|5.9|5.8|Benign/Borderline|5512|103529277|Male|Tumors of the Meninges|2005|5.2|5.5|5.3
20+|0.2|0.2|0.2|Malignant|192|103529277|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|5.9|6.2|6.0|Benign/Borderline|5844|104873824|Male|Tumors of the Meninges|2006|5.4|5.7|5.6
20+|0.2|0.2|0.2|Malignant|179|104873824|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
20+|5.8|6.2|6.0|Benign/Borderline|5946|106190726|Male|Tumors of the Meninges|2007|5.5|5.7|5.6
20+|0.2|0.2|0.2|Malignant|211|106190726|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.1|6.5|6.3|Benign/Borderline|6403|107485679|Male|Tumors of the Meninges|2008|5.8|6.1|6.0
20+|0.2|0.2|0.2|Malignant|187|107485679|Male|Tumors of the Meninges|2008|0.1|0.2|0.2
20+|6.3|6.6|6.5|Benign/Borderline|6531|106701304|Male|Tumors of the Meninges|2009|6.0|6.3|6.1
20+|0.1|0.2|0.2|Malignant|172|106701304|Male|Tumors of the Meninges|2009|0.1|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|682|102226461|Male|Unclassified Tumors|2004|0.6|0.7|0.7
20+|0.6|0.8|0.7|Malignant|618|102226461|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|779|103529277|Male|Unclassified Tumors|2005|0.7|0.8|0.8
20+|0.6|0.7|0.7|Malignant|604|103529277|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|804|104873824|Male|Unclassified Tumors|2006|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|579|104873824|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|802|106190726|Male|Unclassified Tumors|2007|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|579|106190726|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.8|0.9|0.9|Benign/Borderline|867|107485679|Male|Unclassified Tumors|2008|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|630|107485679|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|903|106701304|Male|Unclassified Tumors|2009|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|602|106701304|Male|Unclassified Tumors|2009|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|99|102226461|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|102226461|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|109|103529277|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103529277|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|128|104873824|Male|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|104873824|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|117|106190726|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|106190726|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|139|107485679|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|107485679|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|133|106701304|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|106701304|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|211225769|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211225769|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213680406|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213680406|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|42|216203412|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216203412|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|218722925|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218722925|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|221177242|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|221177242|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|219413878|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|219413878|Male and Female|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1213|211225769|Male and Female|Anaplastic astrocytoma|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1179|213680406|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1170|216203412|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1176|218722925|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1188|221177242|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.5|0.5|Malignant|1132|219413878|Male and Female|Anaplastic astrocytoma|2009|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|375|211225769|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.2|Malignant|354|213680406|Male and Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|340|216203412|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|325|218722925|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|345|221177242|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|306|219413878|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1203|211225769|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1189|213680406|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1172|216203412|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1142|218722925|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1084|221177242|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|974|219413878|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|60|211225769|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211225769|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|70|213680406|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213680406|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|64|216203412|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216203412|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|218722925|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218722925|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|70|221177242|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|221177242|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|69|219413878|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|219413878|Male and Female|Choroid plexus|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|379|211225769|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211225769|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|399|213680406|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213680406|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|371|216203412|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216203412|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|395|218722925|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218722925|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|396|221177242|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|221177242|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|391|219413878|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|219413878|Male and Female|Craniopharyngioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|254|211225769|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|278|213680406|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|292|216203412|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|304|218722925|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|335|221177242|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|341|219413878|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|162|211225769|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|189|213680406|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|165|216203412|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|217|218722925|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|208|221177242|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|224|219413878|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|250|211225769|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211225769|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|262|213680406|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213680406|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|301|216203412|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216203412|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|246|218722925|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218722925|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|245|221177242|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|221177242|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|231|219413878|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|219413878|Male and Female|Ependymoma variants|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|580|211225769|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|590|213680406|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|571|216203412|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|566|218722925|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|614|221177242|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|630|219413878|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|43|211225769|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211225769|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|213680406|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|61|213680406|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|216203412|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216203412|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|218722925|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|80|218722925|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|221177242|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|221177242|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|219413878|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|219413878|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9527|211225769|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Glioblastoma|2005|~|~|~
20+|4.3|4.5|4.4|Malignant|9609|213680406|Male and Female|Glioblastoma|2005|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9736|216203412|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10105|218722925|Male and Female|Glioblastoma|2007|4.5|4.7|4.6
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10315|221177242|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Glioblastoma|2009|~|~|~
20+|4.2|4.4|4.3|Malignant|9998|219413878|Male and Female|Glioblastoma|2009|4.5|4.6|4.6
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|846|211225769|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|832|213680406|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|832|216203412|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|856|218722925|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|221177242|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|875|221177242|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|219413878|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|874|219413878|Male and Female|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|458|211225769|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211225769|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|492|213680406|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213680406|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|484|216203412|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216203412|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|447|218722925|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218722925|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|507|221177242|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|221177242|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|455|219413878|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|219413878|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|364|211225769|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211225769|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|431|213680406|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213680406|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|488|216203412|Male and Female|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216203412|Male and Female|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|561|218722925|Male and Female|Hemangioma|2007|0.2|0.3|0.3
20+|~|~|~|Malignant|~|218722925|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|690|221177242|Male and Female|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|221177242|Male and Female|Hemangioma|2008|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|786|219413878|Male and Female|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|219413878|Male and Female|Hemangioma|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|50|211225769|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|47|213680406|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|53|216203412|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|45|218722925|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|52|221177242|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|49|219413878|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1327|211225769|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1415|213680406|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1418|216203412|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.6|0.6|Malignant|1354|218722925|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.6|Malignant|1452|221177242|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1343|219413878|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.6|0.6
20+|8.7|8.9|8.8|Benign/Borderline|18703|211225769|Male and Female|Meningioma|2004|8.7|9.0|8.9
20+|0.2|0.2|0.2|Malignant|453|211225769|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.2|9.5|9.4|Benign/Borderline|20238|213680406|Male and Female|Meningioma|2005|9.3|9.6|9.5
20+|0.2|0.2|0.2|Malignant|430|213680406|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|9.6|9.8|9.7|Benign/Borderline|21359|216203412|Male and Female|Meningioma|2006|9.7|10.0|9.9
20+|0.2|0.2|0.2|Malignant|395|216203412|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|9.7|9.9|9.8|Benign/Borderline|21987|218722925|Male and Female|Meningioma|2007|9.9|10.2|10.1
20+|0.2|0.2|0.2|Malignant|432|218722925|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|10.0|10.3|10.1|Benign/Borderline|23114|221177242|Male and Female|Meningioma|2008|10.3|10.6|10.5
20+|0.1|0.2|0.2|Malignant|346|221177242|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|10.3|10.5|10.4|Benign/Borderline|23662|219413878|Male and Female|Meningioma|2009|10.6|10.9|10.8
20+|0.1|0.2|0.1|Malignant|322|219413878|Male and Female|Meningioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|473|211225769|Male and Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|552|213680406|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|619|216203412|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|567|218722925|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|571|221177242|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|618|219413878|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|0.6|0.7|0.6|Benign/Borderline|1315|211225769|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1306|211225769|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1420|213680406|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1306|213680406|Male and Female|Neoplasm, unspecified|2005|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1353|216203412|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1287|216203412|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1344|218722925|Male and Female|Neoplasm, unspecified|2007|0.6|0.6|0.6
20+|0.5|0.6|0.5|Malignant|1213|218722925|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1344|221177242|Male and Female|Neoplasm, unspecified|2008|0.6|0.6|0.6
20+|0.6|0.6|0.6|Malignant|1359|221177242|Male and Female|Neoplasm, unspecified|2008|0.6|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1344|219413878|Male and Female|Neoplasm, unspecified|2009|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|1297|219413878|Male and Female|Neoplasm, unspecified|2009|0.6|0.6|0.6
20+|2.2|2.3|2.3|Benign/Borderline|4846|211225769|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|47|211225769|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5146|213680406|Male and Female|Nerve sheath, benign and malignant|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|51|213680406|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5192|216203412|Male and Female|Nerve sheath, benign and malignant|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|216203412|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|5165|218722925|Male and Female|Nerve sheath, benign and malignant|2007|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|61|218722925|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.2|2.3|2.2|Benign/Borderline|5091|221177242|Male and Female|Nerve sheath, benign and malignant|2008|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|48|221177242|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.1|2.2|2.2|Benign/Borderline|4892|219413878|Male and Female|Nerve sheath, benign and malignant|2009|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|30|219413878|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|47|211225769|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|39|213680406|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|40|216203412|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|50|218722925|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|43|221177242|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|40|219413878|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|313|211225769|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|34|211225769|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|356|213680406|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|52|213680406|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|361|216203412|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|216203412|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|369|218722925|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|218722925|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|392|221177242|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|44|221177242|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|400|219413878|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|38|219413878|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|793|211225769|Male and Female|Oligodendroglioma|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|763|213680406|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|810|216203412|Male and Female|Oligodendroglioma|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|777|218722925|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|726|221177242|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|764|219413878|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|154|211225769|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|211225769|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|144|213680406|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|59|213680406|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|143|216203412|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|53|216203412|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|218722925|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|218722925|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|194|221177242|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|88|221177242|Male and Female|Other mesenchymal|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|174|219413878|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|65|219413878|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211225769|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|269|211225769|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213680406|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|303|213680406|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216203412|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|303|216203412|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218722925|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|298|218722925|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|221177242|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|291|221177242|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|219413878|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|249|219413878|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|26|211225769|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|211225769|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213680406|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213680406|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|42|216203412|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|216203412|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|218722925|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|218722925|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|221177242|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|221177242|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|219413878|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|219413878|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|6998|211225769|Male and Female|Pituitary|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|44|211225769|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.5|3.6|3.5|Benign/Borderline|7582|213680406|Male and Female|Pituitary|2005|3.5|3.6|3.5
20+|0.0|0.0|0.0|Malignant|36|213680406|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|8247|216203412|Male and Female|Pituitary|2006|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|29|216203412|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|8529|218722925|Male and Female|Pituitary|2007|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|33|218722925|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|9071|221177242|Male and Female|Pituitary|2008|4.0|4.2|4.1
20+|~|~|~|Malignant|~|221177242|Male and Female|Pituitary|2008|~|~|~
20+|4.1|4.2|4.2|Benign/Borderline|9202|219413878|Male and Female|Pituitary|2009|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|17|219413878|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|15.9|16.2|16.1|Benign/Borderline|34090|211225769|Male and Female|Total|2004|16.0|16.3|16.1
20+|8.9|9.2|9.0|Malignant|19198|211225769|Male and Female|Total|2004|9.0|9.2|9.1
20+|16.9|17.3|17.1|Benign/Borderline|36841|213680406|Male and Female|Total|2005|17.1|17.4|17.2
20+|8.9|9.1|9.0|Malignant|19435|213680406|Male and Female|Total|2005|9.0|9.2|9.1
20+|17.5|17.8|17.7|Benign/Borderline|38686|216203412|Male and Female|Total|2006|17.7|18.1|17.9
20+|8.8|9.0|8.9|Malignant|19552|216203412|Male and Female|Total|2006|8.9|9.2|9.0
20+|17.6|18.0|17.8|Benign/Borderline|39609|218722925|Male and Female|Total|2007|17.9|18.3|18.1
20+|8.8|9.0|8.9|Malignant|19823|218722925|Male and Female|Total|2007|8.9|9.2|9.1
20+|18.1|18.5|18.3|Benign/Borderline|41476|221177242|Male and Female|Total|2008|18.6|18.9|18.8
20+|8.8|9.0|8.9|Malignant|20199|221177242|Male and Female|Total|2008|9.0|9.3|9.1
20+|18.4|18.8|18.6|Benign/Borderline|41947|219413878|Male and Female|Total|2009|18.9|19.3|19.1
20+|8.5|8.7|8.6|Malignant|19486|219413878|Male and Female|Total|2009|8.8|9.0|8.9
20+|2.2|2.3|2.3|Benign/Borderline|4846|211225769|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|47|211225769|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5149|213680406|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|51|213680406|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5194|216203412|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|40|216203412|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|5167|218722925|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.3|2.4|2.4
20+|0.0|0.0|0.0|Malignant|61|218722925|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.2|2.3|2.2|Benign/Borderline|5095|221177242|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|48|221177242|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.1|2.2|2.2|Benign/Borderline|4897|219413878|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|30|219413878|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|822|211225769|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.3|7.6|7.5|Malignant|15851|211225769|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.4|7.6|7.5
20+|0.4|0.5|0.4|Benign/Borderline|919|213680406|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.3|7.5|7.4|Malignant|16011|213680406|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.4|7.6|7.5
20+|0.4|0.5|0.5|Benign/Borderline|976|216203412|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|16194|216203412|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.4|7.6|7.5
20+|0.4|0.5|0.4|Benign/Borderline|955|218722925|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|7.3|7.5|7.4|Malignant|16522|218722925|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.4|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|995|221177242|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|7.3|7.5|7.4|Malignant|16749|221177242|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.5|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|972|219413878|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|7.1|7.3|7.2|Malignant|16303|219413878|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.3|7.5|7.4
20+|3.4|3.6|3.5|Benign/Borderline|7377|211225769|Male and Female|Tumors of Sellar Region|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|44|211225769|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.7|3.8|3.7|Benign/Borderline|7981|213680406|Male and Female|Tumors of Sellar Region|2005|3.7|3.8|3.7
20+|0.0|0.0|0.0|Malignant|37|213680406|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8618|216203412|Male and Female|Tumors of Sellar Region|2006|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|31|216203412|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.0|4.1|4.1|Benign/Borderline|8924|218722925|Male and Female|Tumors of Sellar Region|2007|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|33|218722925|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.2|4.3|4.3|Benign/Borderline|9467|221177242|Male and Female|Tumors of Sellar Region|2008|4.2|4.4|4.3
20+|~|~|~|Malignant|~|221177242|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|4.3|4.4|4.3|Benign/Borderline|9593|219413878|Male and Female|Tumors of Sellar Region|2009|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|17|219413878|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|9.0|9.2|9.1|Benign/Borderline|19315|211225769|Male and Female|Tumors of the Meninges|2004|9.0|9.3|9.1
20+|0.2|0.3|0.2|Malignant|503|211225769|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|9.5|9.8|9.7|Benign/Borderline|20874|213680406|Male and Female|Tumors of the Meninges|2005|9.6|9.9|9.8
20+|0.2|0.3|0.2|Malignant|492|213680406|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|9.9|10.1|10.0|Benign/Borderline|21986|216203412|Male and Female|Tumors of the Meninges|2006|10.0|10.3|10.2
20+|0.2|0.2|0.2|Malignant|453|216203412|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.0|10.2|10.1|Benign/Borderline|22590|218722925|Male and Female|Tumors of the Meninges|2007|10.2|10.5|10.3
20+|0.2|0.2|0.2|Malignant|503|218722925|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|10.3|10.6|10.4|Benign/Borderline|23815|221177242|Male and Female|Tumors of the Meninges|2008|10.6|10.9|10.8
20+|0.2|0.2|0.2|Malignant|438|221177242|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|10.5|10.8|10.7|Benign/Borderline|24291|219413878|Male and Female|Tumors of the Meninges|2009|10.9|11.2|11.1
20+|0.2|0.2|0.2|Malignant|389|219413878|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|0.8|0.8|0.8|Benign/Borderline|1684|211225769|Male and Female|Unclassified Tumors|2004|0.8|0.8|0.8
20+|0.6|0.7|0.6|Malignant|1320|211225769|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1855|213680406|Male and Female|Unclassified Tumors|2005|0.8|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1321|213680406|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|1850|216203412|Male and Female|Unclassified Tumors|2006|0.8|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1303|216203412|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1910|218722925|Male and Female|Unclassified Tumors|2007|0.8|0.9|0.9
20+|0.5|0.6|0.5|Malignant|1225|218722925|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|2044|221177242|Male and Female|Unclassified Tumors|2008|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|1381|221177242|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2133|219413878|Male and Female|Unclassified Tumors|2009|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|1314|219413878|Male and Female|Unclassified Tumors|2009|0.6|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|151|211225769|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211225769|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|147|213680406|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213680406|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|171|216203412|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|216203412|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|174|218722925|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218722925|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|190|221177242|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|54|221177242|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|194|219413878|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|219413878|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
